
Shp2 regulates SRC family kinase activity and Ras/Erk ... - PubMed
Feb 13, 2004 · Additional Shp2 functions downstream of, or parallel to, Ras/Erk activation also are proposed. Here, we show that Shp2 promotes Src family kinase (SFK) activation by regulating the phosphorylation of the Csk regulator PAG/Cbp, thereby controlling Csk access to SFKs.
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in ...
In each tumor that was sensitive to combined treatment, p (Y542) SHP2 induction was observed in response to ERK signaling inhibition. The strategy was broadly effective in TNBC models and tumors with RAS mutations at G12, whereas tumors …
SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling
Oct 25, 2019 · To explain how the phosphatase activity of SHP-2 stimulates the RAS-ERK pathway, five mechanisms have been proposed. First, SHP-2 was shown to dephosphorylate specific positions of the receptor (e.g., PDGFR) or GAB thus preventing the recruitment of the RAS-GTPase activating protein RAS-GAP (Figure 2A) (47–51). Opposite to SOS, RAS-GAP ...
Molecular Mechanism for the Shp-2 Tyrosine Phosphatase …
In this report, we describe several novel observations important for understanding the function of Shp-2 in promoting the Erk pathway. First, biochemical evidence suggests that Shp-2 acts upstream of Ras in the induction of Erk activity by EGF.
Shp2 Regulates Src Family Kinase Activity and Ras/Erk …
Feb 13, 2004 · Shp2 is required to sustain Ras/Erk activation in response to RTK stimulation. Recent studies implicate EM Ras activation, mediated via Src/Plcγ1-dependent stimulation of RasGRPs, in this process (Bivona et al., 2003).
SHP2 Inhibition Suppresses RAS-ERK Signaling, the Development …
Nov 15, 2022 · These analyses revealed altered levels of phosphorylation in persistent cells, including peptides belonging to SHP2, an oncogenic phosphatase known to regulate JAK-STAT signaling as well as RAS-ERK activation and which has been shown to contribute to adaptive resistance to targeted cancer therapies.
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in ...
Jan 2, 2019 · In each tumor that was sensitive to combined treatment, p(Y542)SHP2 induction was observed in response to ERK signaling inhibition. The strategy was broadly effective in TNBC models and tumors with RAS mutations at G12, whereas tumors with RAS(G13D) or RAS(Q61X) mutations were resistant.
A comprehensive review of SHP2 and its role in cancer
Sep 6, 2022 · The rat sarcoma (Ras)/ERK pathway is a well-established major signaling pathway modulated by SHP2 downstream of RTKs in different cell types [1, 10, 123]. SHP2 regulates cell proliferation, survival, differentiation, migration and metabolism primarily through activation of this pathway [28, 122].
Strategies to overcome drug resistance using SHP2 inhibitors
Encoded by PTPN11, the SHP2 (Src homology-2 domain-containing protein tyrosine phosphatase-2) is widely recognized as a carcinogenic phosphatase. As a promising anti-cancer drug target, SHP2 regulates many signaling pathways such …
Excitatory neuron-specific SHP2-ERK signaling network regulates ...
Mar 5, 2019 · Here, we found that expressing the NS-associated mutant SHP2 D61G in excitatory, but not inhibitory, hippocampal neurons increased ERK signaling and impaired both long-term potentiation (LTP) and spatial memory in mice, although endogenous SHP2 was expressed in both neuronal types.